AMGEN INC (AMGN)
@AMGN.asset
$296.30
At close:
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Figures
- Sector Healthcare
- Industry Biotechnology
- Index S&P 500
- Market Cap $159.52 B
- Last Earnings Report Aug 6, 2025
- Price Reaction to Earnings Report -5.48%
- Enterprise Value $207.69 B
- Dividend Yield 0.03%
- P/E ratio 24.07
- Price/Sales ratio 4.56
- EV/Sales ratio 5.95
- Price/Book Value 21.45
- Revenue $34.92 B
- EBIT $10.36 B
- Net Income $6.62 B
- Gross Profit $22.52 B
- Free Cash Flow $10.61 B
- EBIT Margin 29.68%
- Gross Margin 64.48%
- FCF Margin 30.37%
- Return on Equity 89.11%
- Equity Ratio 8.45%
- Debt/Equity Ratio 10.83
- 6-month Performance 7.59%
- 12-month Performance -4.07%
- Trend reversal good
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |